NasdaqCM - Nasdaq Real Time Price • USD
60 Degrees Pharmaceuticals, Inc. (SXTP)
At close: June 7 at 4:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Geoffrey Stuart Dow | Chairman, CEO & President | 125.56k | -- | 1974 |
| Mr. Tyrone Miller | CFO & Treasurer | 135.63k | -- | 1975 |
| Dr. Bryan Smith | Chief Medical Officer | -- | -- | 1966 |
| Ms. Kristen Landon | Chief Commercial Officer | -- | -- | 1967 |
| Ms. Jennifer Herz | Director | -- | -- | -- |
60 Degrees Pharmaceuticals, Inc.
1025 Connecticut Avenue NW
Suite 1000
Washington, DC 20036
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 3
Description
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.
Corporate Governance
60 Degrees Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
CLDI Calidi Biotherapeutics, Inc.
0.1930
-0.52%
VIRI Virios Therapeutics, Inc.
0.2280
-3.39%
CANF Can-Fite BioPharma Ltd.
2.4700
-3.39%
KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
GOVX GeoVax Labs, Inc.
1.6100
-6.40%
FRES Fresh2 Group Limited
0.4375
-5.91%
INM InMed Pharmaceuticals Inc.
0.2354
-7.69%
DYAI Dyadic International, Inc.
2.0200
-8.18%
SCNI Scinai Immunotherapeutics Ltd.
2.9700
-25.94%